I’m going to let you in on a Silicon Valley secret.
It’s a secret that the leaders of the U.S. tech sector guard very closely.
And I only know about it because I regularly talk to the senior industry executives as I make my rounds out here.
Each and every leader of the top tech players maintains a secret “Silicon Valley Watch List” – in essence, a ranked short list of companies they’d one day like to buy.
These “Watch List” companies are so good, in fact, that once they’re purchased, they immediately bolster the suitor company’s bottom line.
If those characteristics sound familiar to you, it’s with good reason.
You see, those are essentially the qualities that I’ve repeatedly detailed for you in Your Tech Wealth Blueprint.
And today I’m going to show you some great examples of “Silicon Valley Watch List” companies that turned into mega-deal buyouts – and demonstrate how you can set up your portfolio to grab a share of these tech-sector windfalls.
And the profits are huge.
Make no mistake: The so-called “mergers and acquisitions (M&A) market is white-hot. As recently told you in our discussion about tech’s top dividend players, U.S. companies are awash in cash … tens of billions of dollars, in fact.
That gives tech-sector CEOs a lot of deal-making ammo. And they’re using it.
Around the world, bankers have been keeping busy helping firms tie the knot. Thus far in 2016, we’ve seen more than $2 trillion worth of deal announcements, with more than 40% of that action taking place here in the United States.
And as is the case in most years, the tech sector leads the way.
According to Dealogic, global technology acquisitions thus far in 2016 have surpassed $400 billion, up 27% from the same period last year. We’re within striking distance of the all-time record set last year.
Simply put, this M&A tech frenzy won’t go away any time soon. It’s been a key theme for investors going back since 2000, and it will remain a key theme in coming decades as long as young, innovative firms pioneer new technologies that the big firms must control.
So CEOs view today’s markets as “target rich” environments.
And there’s no reason you shouldn’t ride along and pocket some hefty gains, too.
Let’s look at some recent deals – first, the one that created those 48%-in-a-day gains
In mid-June – in one of the biggest tech deals ever – Microsoft Corp. (Nasdaq: MSFT) announced its intention to buy LinkedIn Corp. (NYSE: LNKD) for $26.2 billion. That pact moves Satya Nadella’s software/mobile/cloud computing firm into business-focused social networking.
On Friday, June 10, before the deal was announced, LinkedIn shares closed at $131.08 each.
By the time the stock-market closed on Monday, June 13, LinkedIn was at $192.21 a share.
That represented a one-day pop of 47%.
In another historically large tech deal, Japan’s SoftBank Group Corp. (OTC: SFTBF), a web and telecom conglomerate, decided to buy U.K. chipmaker ARM Holdings PLC (Nasdaq ADR: ARMH). SoftBank made the $32 billion move to expand into the Internet of Everything and plans to produce 1 trillion ARM chips in the next 20 years.
That led to a one-day pop of 40.5%.
Earlier this month, Wal-Mart Stores Inc. (NYSE: WMT) agreed to pay $3.3 billion to buy online discount retailer Jet.com Inc.
Also this year, Apple Inc. (Nasdaq: AAPL) agreed to buy Turi, a machine-learning and artificial intelligence startup, for an undisclosed sum; Uber Inc. is selling its Chinese business unit to Didi Chuxing, the leading ride-hailing service in China; and Salesforce.com Inc. (NYSE: CRM) inked a deal to pick up Quip, a maker of word-processing tools, for $582 million.
And database and software leader Oracle Corp. (Nasdaq: ORCL) agreed to buy cloud-computing pioneer NetSuite Inc. (NYSE: N) for $9.3 billion. Oracle is a serial acquirer that has made dozens of deals in recent years to add new products and sector plays.
Of course, many tech mergers still come about because the buying firm wants to take out overlapping products from a competitor and lower costs. That was a big driver behind the $14.8 billion bid Analog Devices Inc. (NYSE: ADI) made for rival Linear Technology Corp. (Nasdaq: LLTC).
There’s a simple reason why big U.S. companies like Microsoft and Wal-Mart play such an integral role in the M&A market.
They’re looking to “buy” growth.
When companies get as big as Microsoft – and with as much cash – it usually means that their business has “matured,” Wall Street speak for slowing growth.
And these deals means the acquiring firm needs to fill in the franchise by entering new markets or getting new products.
Take this 2013 example from networking giant Cisco Systems Inc. (Nasdaq: CSCO).
Over the past 20 years, Cisco has engineered well over 100 acquisitions. Most of these were smaller deals involving companies few investors ever heard of.
But in July 2013, then-Cisco CEO John Chambers said he would buy cybersecurity leader Sourcefire LLC for $2.7 billion. On paper, it looked to be a great fit for Cisco.
Cisco’s business is all about the web, a platform that remains under constant attack from hackers. Cisco wants to be able to offer its customers improved network security, and the Sourcefire buyout was the most cost-effective way to do that.
The same forces are at work in the biopharma sector.
The chance to fill out its franchise appealed heavily to big drug firm Pfizer Inc. (NYSE: PFE). Its planned $160 billion merger with Allergan may have fell through, but Pfizer picked up Anacor Pharmaceuticals Inc. (Nasdaq: ANAC) for $5.2 billion in May and just penned a deal to buy Medivation Inc. (Nasdaq: MDVN) for $14 billion.
Whenever deals like this gets announced, I always hear some investors trying to guess who the next takeover target will be. Unfortunately, some investors will actually buy stocks on speculation the firm will get bought out.
That’s a mistake.
Never buy a stock solely on the hope that a buyout will take place. You have to believe in the prospects for the underlying company, too.
That way, if a deal never materializes – and you end up as a long-term “owner” of the stock – at least you’ll own a company with the potential for growth.
If you don’t believe in the company, you could get left holding a stock whose fundamentals are so weak that the stock could collapse – inflicting you with a painful loss.
That brings us to the next point – and it’s an important one: How can you profit from these deals?
Because there is a way to do this …
The Art of the Deal
If you want to boost your odds for getting in on the Silicon Valley Watch List – and the massive gains that follow when those firms get acquired – focus on buying high-quality tech firms, with a special emphasis on small- and mid-cap players.
And you can do that by following the five-rule system that I’ve established for you here at the Strategic Tech Investor.
Those rules are worth reviewing. They are:
- Tech Wealth Rule No. 1: Identify Companies With Great Operations.
- Tech Wealth Rule No. 2: Separate the Signals From the Noise.
- Tech Wealth Rule No. 3: Ride the Unstoppable Trends.
- Tech Wealth Rule No. 4: Focus on Growth.
- Tech Wealth Rule No. 5: Target Stocks That Can Double Your Money.
Inogen is pioneering the use of portable oxygen concentrators (POCs). And the Goleta, Calif.-based firm boasts breakthrough technology that has disrupted its entire sector.
Traditionally, people who need home-based oxygen therapy have had to depend on tanks or bottles filled with a limited supply of oxygen – or an oxygen concentrator too big and bulky to travel with.
Instead of storing oxygen, Inogen’s POCs remove nitrogen from the ambient air and deliver pure oxygen to patients – and they work as long as their batteries stay charged. While oxygen-concentration technology has been around for decades, only since 2000 have portable versions become reliable – and only since 2009 has the Federal Aviation Administration allowed POCs on U.S. flights.
At the time – because it passed through all five of our tech wealth “filters” – I predicted that it would take roughly 2.8 years for Inogen’s stock to give us 100% gains.
A little less than a year and a half later, you’re sitting on gains of 80% — so my forecast is looking good.
Now, Inogen has not been acquired since then but, as a small-cap medtech firm, I feel certain that it’s on the Silicon Valley Watch List.
So, it turns out that the single best way to put yourself in a position to capture M&A profits is to follow the system I’ve laid out here for you at Strategic Tech Investor.
With that system, you’ve already made 80% — and if Inogen gets picked up, you’ll make a whole lot more.
So follow along with me each week. I’m working on even more reports to keep you informed of all the M&A activity that I feel you can benefit from right away.
See you Friday.
- Strategic Tech Investor: Your Tech Wealth Blueprint.
- Strategic Tech Investor: You Love Dividends – and Now Silicon Valley Does, Too.
- Strategic Tech Investor: All Five Rules Point to a Quick Double on This Stock.
- Strategic Tech Investor: How to Profit From M&A – No Crystal Ball Required.